Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the Norepinephrine and Serotonin Reuptake Inhibitor Levomilnacipran in Healthy Males

NCT03249311 is registered in ClinicalTrials.gov with University of Ottawa as lead sponsor.

NCT NCT03249311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03249311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the Norepinephrine and Serotonin Reuptake Inhibitor Levomilnacipran in Healthy Males
Lead sponsor
University of Ottawa
Phase
Phase 4
Overall status
Unknown status
Start date
March 2, 2018
Completion date
May 1, 2022
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

none (i.e. healthy volunteers)